1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Antibiotics, medicinal plants, superbugs and the coming antimicrobial resistant drugs pandemic : global markets, competitors and opportuninites - 2014 - 2019 Analysis and Forecasts

An Antibiotic is an agent that either kills or inhibits the growth of a microorganism. The world is now facing a grave situation: it is losing the battle against infectious diseases; bacteria are fighting back and are becoming resistant to modern medicine; in short, pharmaceutical drugs don’t work. If resistance is allowed to increase, in a few decades people may start dying from the most commonplace of ailments that today can be treated easily. In fact, the ability of organisms to develop resistance to the effects of antimicrobial therapies developed to kill them is potentially the greatest challenge to healthcare in the 21st century.

Antimicrobial resistance (AMR) is a form of drug resistance whereby some sub-populations of a microorganism, usually a bacterial species, are able to survive after exposure to one or more antibiotics. Pathogens resistant to multiple antibiotics are considered multidrug resistant (MDR) or, more colloquially, superbugs.

The US and world are in the beginning of an emerging crisis of Antibiotic resistance for microbial pathogens. Epidemic antibiotic resistance has been described in numerous pathogens in varying contexts, including, but not limited to: MRSA (methicillin-resistant Staphylococcus aureus), common respiratory pathogens, including Streptococcus pneumoniae and Mycobacterium tuberculosis, and epidemic increases in multidrug-resistant and, increasingly, truly pan-resistant, gram-negative bacilli.

Why is the level of concern increasing now? It is because the increase in organisms resistant to multiple therapies is now coinciding with the reduction in new therapies coming to market to replace ineffective ones.

Herbal medicine, including medicinal plants, was the only way people could treat infectious diseases until the early 20th century. Since then, pharmaceutical drugs have become the main method for treating bacterial infections. However, the pharmaceutical drug pipeline is almost dry. At the same time, growing consumer awareness of the benefits of herbal medicine, along with a backlash against the exorbitant prices and dangerous side effects of pharmaceutical drugs, have led to a renaissance in the use of medicinal plants. Consumers are starting to focus on keeping healthy rather than dealing with acute situations that require the use of expensive pharmaceutical drugs. Medicinal plants fit perfectly into this new paradigm. And for this reason, their use is forecast to grow dramatically.

This report looks at the use of medicinal plants, rather than Antibiotics, to both treat and prevent bacterial infections.

Specifically, it provides:

• A detailed look at Antibiotics and Antimicrobial Resistant drugs.
• Analysis of the Antibiotics market.
• In-depth examination of Antibacterial Medicinal Plants.
• Analysis of the Medicinal Plants market.

Additionally, profiles of 127 private and public companies involved in the Antibiotics and Medicinal Plants industries as producers, distributors, and retailers are given. The report also includes 32 tables and 32 figures.

Table Of Contents

Antibiotics, medicinal plants, superbugs and the coming antimicrobial resistant drugs pandemic : global markets, competitors and opportuninites - 2014 - 2019 Analysis and Forecasts

- Background, Spread of MRSA to Households, New Delhi Metallo, Consumers Moving Toward Herbal Medicine, Mainstream Medical Establishments Changing Their Thinking, Consumer Focus Now on Maintaining Health, Outlook for Medicinal Plants Vs. Antibiotic Drugs
- Report Objectives
- Methodology and Sources
- Statistical Notes



- Antibiotics
- Antibiotic Resistance
- Epidemic of Antibiotic-Resistant Infections
- Grave Situation
- Modern Healthcare Built on Antimicrobials
- History of Antimicrobial Resistance
- Putting the Problem in Context
- Fallacy of Antibiotic Overuse
- Decreasing Antibiotic Development
- Increasing Costs, Decreasing ROI
- Lack of FDA Guidance
- Companies Developing New Antibiotic Drugs
- Government Efforts
- Multi-Drug Resistance Growing
- Current Situation
- Number of AMR Cases Each Year by Type
- More Needs to Be Done
- Incentive Problems
- Economic Costs
- Cost of MRSA
- Paradox of Low Impact
- Limits of Costs of Resistance Assessments
- Outlook
- Reducing Uncertainty and Increasing Knowledge
- Developing Better Incentives
- International Activity


- Total Market
- Market by Type
- Market by Region
- Market by Application
- Market Commoditization
- Competitive Environment
- Market Opportunities
- Gram-negative Market
- Clostridium difficile-Associated Diarrhea (CDAD)
- Market Landscape for CDAD Treatments
- Fecal Matter Transplants (FMTs)
- Gram-positive Market


- Historical Context
- Single-Ingredient Drugs
- Big Pharma Lost Interest in Plants 20 Years Ago
- Need for New Strategies
- Case Against Plants
- Need for New Technologies
- FDA and Botanical Drugs
- First Botanical Drug NDA
- First Oral Botanical Drug NDA
- Future of Botanical Drug Products in the US
- International Botanical Drugs
- Why Biological Drugs Are Needed
- Future of Botanical Drugs in the US
- Scarcity of Disease in Wild Plants
- Why New Antimicrobial Substances from Plants
- Plants as a Source of Antimicrobials
- Plants Synthesize Target-Specific Antibacterials
- Synergy and Multidrug Resistance Pump Inhibitors
- Plant Antibacterials Function in Synergy
- Targeting Bacterial Virulence
- Future Directions
- Plant Antibacterials
- MDR Inhibitors
- Block Pathogen Virulence
- Antimicrobial Resistance and Phytochemicals
- New Therapy Against Resistance
- Phytotherapy
- Phytochemicals and Their Classes
- Secondary Metabolites
- Phenolics and Polyphenols
- Mode of Action of Phytochemicals
- Biofilms and Phytochemicals
- Quorum-Sensing
- Phytochemical Products as Antimicrobials and in Biofilm Control
- Anti-staphylococcal Plant Natural Products
- Resistance Modifying Agents
- Methicillin-resistance Reversing Agents
- Modulators of Multidrug Resistance
- Antibacterial Natural Products
- Topical Materials
- Biological Warfare
- List of Antimicrobial Plants


- Market Size Estimation Issues
- Global Medicinal Plant Production
- Global Medicinal Plant Exports
- Global Medicinal Plant Imports
- Global Medicinal Plant Production by Type
- Competitive Environment


A.A. Sayia and Company, Inc.
A. Baur and Co (Pvt.) Ltd.
Adam Group
Adams Extract and Spice, LLC,
Akbar Brothers Ltd.
Alchem International
Alvita Tea
Ambo Exports
A. M. Todd Botanical Therapeutics, LLC
Asian Tea and Exports Ltd.
Balaji Agro International
Bart Ingredients Company Ltd
Bigelow Tea Company
Bio Foods Pvt Ltd
Brassica Teas
Cape Natural Tea Products

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Benzyl Alcohol Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Benzyl Alcohol Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • August 2016
  • by Transparency Market Research

Benzyl alcohol is an aromatic alcohol, which is metabolized into benzoic acid inthe human body. Benzyl alcohol is manufactured by hydrolysis of benzyl chloride in the presence of soda ash through the toluene ...

Asia-Pacific Animal Health Market - Forecast to 2021

Asia-Pacific Animal Health Market - Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The APAC animal health market is estimated to grow at a CAGR of 5.7% during the forecast period, to reach USD 20.25 billion by 2021 from USD 15.32 billion in 2016. Growth in this market can primarily be ...

Silver Sulfadiazine Market: By Application (Wound Care, Burn Care, Skin Care, UTIs) & By Geography -Forecast (2016-2021)

Silver Sulfadiazine Market: By Application (Wound Care, Burn Care, Skin Care, UTIs) & By Geography -Forecast (2016-2021)

  • $ 5250
  • Industry report
  • September 2016
  • by Industry ARC

Silver sulfadiazine is an antibacterial drug used for making personal care products. Silver sulfadiazine is listed as the essential medicines by World Health Organization and is widely used as an antibiotic ...

Global Feed Antibiotics Market

October 2016 $ 4250


Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.